Lack of Association of Interleukin-1 Gene Cluster Polymorphisms with Angiographically Documented Coronary Artery Disease: Demonstration of Association with Hypertension in the Polish Population

Archives of Medical Research

Volumn 42, Issue 5, 2011, Pages 426-432

  Goracy, Jarosław ^a   Goracy, Iwona ^a   Safranow, Krzysztof ^a   Taryma, Olga ^a   Adler, Grazyna ^a   Ciechanowicz, Andrzej ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Coronary artery disease; Hypertension; IL1 ; IL1RN; Polymorphism

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; VARIABLE NUMBER OF TANDEM REPEAT;

BASE SEQUENCE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DNA PRIMERS; HUMANS; INTERLEUKIN-1; MULTIGENE FAMILY; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 80052752654     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.08.002     Document Type: Article

References (39)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 34:115-126.
2. Dinarello C.A. Proinflammatory cytokines. Chest 2000, 118:503-508.
3. Bochner B.S., Luscinskas F.W., Gimbrone M.A., et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1 activated endothelial cells: contributions of endothelial adhesion molecules. J Exp Med 1991, 173:1553-1557.
4. Bevilaqua M.P., Pober S., Majeau G.R., et al. Interleukin-1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984, 160:618-623.
5. Arend W.P., Malyak M., Guthridge C.J., et al. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998, 16:27-55.
6. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
7. Pociot F., Molving J., Wogensen L., et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992, 22:396-402.
8. Hurme M., Santilla S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 1998, 28:2598-2602.
9. Tseng L.H., Chen P.J., Lin M.J., et al. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001, 57:318-324.
10. Marculescu R., Endler G., Schilinger M., et al. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 2002, 51:3582-3585.
11. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scan J Immunol 1998, 47:195-198.
12. Hwang I.R., Kodama T., Kikuchi S., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1(beta) production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
13. Blakemore A.I., Tarlow J.K., Cork M.J., et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994, 37:1380-1385.
14. Mansfeld J.C., Holden H., Tarlow J.K., et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994, 106:637-642.
15. Korman K.S., Crane A., Wang H.Y., et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Peridontol 1997, 24:72-77.
16. Alpert J.S., Thygesen K. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000, 21:1502-1513.
17. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992, 48:361-372.
18. Iacoviello L., Di Castelnuovo A., Gattone M., et al. Polymorphism of the interleukin 1 gene affect the risk of myocardial infarction and ischaemic stroke at young age and response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005, 25:222-227.
19. Momiyama Y., Hirano R., Taniguchi H., et al. Effects of interleukin-1β gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infections. J Am Coll Cardiol 2001, 38:712-717.
20. Rios D.L.S., Cerqueira C.C.S., Bonfim-Silva R., et al. Interleukin-1 beta and interleukin-6 polymorphism associations with angiographically assessed coronary artery disease in Brasilians. Cytokine 2010, 50:292-296.
21. Zhang Y.M., Zhong L.J., He B.X., et al. The correlation between polymorphism at position -511 C/T in the promoter region of interleukin 1B and the severity of coronary heart disease. Zhonhua Yi Xue Yi Chuan Xue Za Zhi 2006, 23:86-88.
22. Miranda-Malpica E., Martinez-Rios M.A., Fragoso J.M., et al. The interleukin 1B-511 polymorphism is associated with risk of developing restenosis after coronary stenting in Mexicans patients. Hum Immunol 2008, 69:116-121.
23. van Minkelen R., Wettinger S.B., de Visser M.C., et al. Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis 2009, 203:201-205.
24. Fragoso J.M., Delgadillo H., Llorente L., et al. Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans. Immunol Lett 2010, 133:106-111.
25. Zee R.Y., Lunze K., Lindpaintner K., et al. A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Thromb Haemost 2001, 86:1141-1143.
26. Soylu O., Yildrim A., Coker A., et al. Interleukin-1B (-511) gene polymorphism is associated with acute coronary syndrome in the Turkish population. Eur Cytokine Netw 2008, 19:42-48.
27. Koukkou E., Watts G.F., Mazurkiewicz J., et al. Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin. J Clin Pathol 1994, 47:1105-1107.
28. Waehre T., Ynestad A., Smith C., et al. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation 2004, 109:1966-1972.
29. Marchesi S., Lupatelli G., Sensini A., et al. Racial difference in endothelial function: role of the infective burden. Atherosclerosis 2007, 191:227-234.
30. Ghazouani L., Ben Hadj Khalifa S., Abboud N., et al. TNF-α -308G>A and IL-6 -174G>C polymorphisms in Tunisian patients with coronary artery disease. Clin Biochem 2010, 43:1085-1089.
31. Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., et al. Interleukin 6 -174 G/C promoter polymorphism and risk of coronary heart disease: result from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 2006, 26:212-217.
32. Rechciński T., Grebowska A., Kurpesa M., et al. Interleukin-1β and interleukin-1 receptor inhibitor gene cluster polymorphisms in patients with coronary artery disease after percutaneous angioplasty or coronary artery bypass grafting. Kardiol Pol 2009, 67:601-610.
33. Francis S.E., Camp N.J., Dewberry R.M., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999, 99:861-866.
34. Dalekos G.N., Bairaktari E., Tsolas O., et al. Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?. J Lab Clin Med 1997, 129:300-308.
35. Dalekos G.N., Elisaf M.S., Papagalanis N., et al. Elevated interleukin-1 beta in the circulation of patients with essential hypertension before any drug therapy: a pilot study. Eur J Clin Invest 1996, 26:936-939.
36. Peeters A.C., Netea M.G., Janssen M.C., et al. Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001, 31:31-36.
37. Huang G., Niu T., Peng S., et al. Association between the interleukin-1β C(-511)T polymorphism and blood pressure in a Chinese hypertensive population. Immunol Lett 2004, 91:159-162.
38. Lin R.C., Morris B.J. Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. Am J Med Genet 2002, 107:311-316.
39. Yanagisawa A., Suzuki K., Kimura A., et al. Possible protective effect of serum β-carotene levels on the association between interleukin-1B C-31T polymorphism and hypertension in a Japanese population. Clin Nutr 2009, 28:198-202.